GGrantIndex
← Leaderboards

Jeffrey Jensen

Oregon Health & Science University

$3,882,169
Attributed
$3,882,169
Total exposure
7
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.6M · FY201025
$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,882,169 · 7

By mechanism

N01$3,574,240 · 7
N03$307,929 · 1

Top collaborators

No co-investigators on record.

Most similar at Oregon Health & Science University

Same institution · by research overlap

Others in their field

Top investigators on “Contraceptive Agents

Research focus

Contraceptive AgentsContraceptive MethodsSafetyClinical Trials NetworkNational Institute Of Child Health And Human DevelopmentClinical TrialsWomanFemale Contraceptive AgentsDrug KineticsObesityProtocols DocumentationMissionSiteContractsContraceptive EfficacyFemaleReproductiveDevicesPharmaceutical PreparationsThromboembolismBaseDrug CandidateEnrollmentFormulation

Grant awards (26)

CCTN-PHARMACOKINETIC / PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION - OREGON$33,674
N01 · FY2025 · HD · contact PI
CCTN-PHARMACOKINETIC / PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION - OREGON$123,417
N01 · FY2024 · HD · contact PI
CCTN-PHARMACOKINETIC / PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION$97,519
N01 · FY2023 · HD · contact PI
CCTN-PHARMACOKINETIC / PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION$160,207
N01 · FY2021 · HD · contact PI
CCTN - CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION - CENTRAL LABORATORY$9,201
N01 · FY2021 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - FEMALE SITES$61,398
N01 · FY2020 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - FEMALE SITES$124,225
N01 · FY2019 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$11,592
N01 · FY2019 · HD · contact PI
CCTN-PHARMACOKINETIC / PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION$208,092
N01 · FY2018 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$11,592
N01 · FY2018 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$14,125
N01 · FY2017 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$11,592
N01 · FY2017 · HD · contact PI
CCTN - CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION - CENTRAL LABORATORY$153,912
N01 · FY2016 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$19,780
N01 · FY2016 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$20,608
N01 · FY2015 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - FEMALE SITES$472,949
N01 · FY2014 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$307,929
N03 · FY2014 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$24,358
N01 · FY2014 · HD · contact PI
CLINICAL EVALUATION NESTORONE/ESTRADIOL-RELEASING VAGINAL RING FOR FEMALE CONTRACEPTION$11,292
N01 · FY2014 · HD · contact PI
CLINICAL EVALUATION NESTORONE/ESTRADIOL-RELEASING VAGINAL RING FOR FEMALE CONTRA$42,548
N01 · FY2013 · HD · contact PI
HORMONE ASSAYS FOR THE DOSE FINDING STUDY FOR LEVONORGESTREL BUTANOATE$561,726
N01 · FY2011 · HD · contact PI
CLINICAL EVALUATION NESTORONE/ESTRADIOL-RELEASING VAGINAL RING FOR FEMALE CONTRA$555,592
N01 · FY2011 · HD · contact PI
PHARMACOKINETIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION$344,104
N01 · FY2011 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$87,476
N01 · FY2011 · HD · contact PI
CLINICAL EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION$36,594
N01 · FY2011 · HD · contact PI
NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK (FEMALE)$376,667
N01 · FY2010 · HD · contact PI